The MYB oncogene can suppress apoptosis in acute myeloid leukemia cells by transcriptional repression of DRAK2 expression

Leukemia Research

Volumn 37, Issue 5, 2013, Pages 595-601

  Ye, Ping ^a   Zhao, Liang ^a   Gonda, Thomas J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Apoptosis; DRAK2 STK17B; Leukemia; MYB; ShRNA

Indexed keywords

CASPASE 9;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL DEATH; CONTROLLED STUDY; DEATH ASSOCIATED PROTEIN KINASE RELATED 2 GENE; DOWN REGULATION; ENZYME ACTIVITY; GENE; GENE EXPRESSION REGULATION; GENE REPRESSION; ONCOGENE MYB; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TARGETING; PROTO ONCOGENE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION SITE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 9; DOWN-REGULATION; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; K562 CELLS; LEUKEMIA, MYELOID, ACUTE; ONCOGENE PROTEINS V-MYB; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RESPONSE ELEMENTS; TRANSCRIPTION, GENETIC; U937 CELLS;

EID: 84875879596     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.01.012     Document Type: Article

References (51)

1. Emambokus N., Vegiopoulos A., Harman B., Jenkinson E., Anderson G., Frampton J. Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb. EMBO J 2003, 22:4478-4488.
2. Mucenski M.L., McLain K., Kier A.B., Swerdlow S.H., Schreiner C.M., Miller T.A., et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 1991, 65:677-689.
3. Sicurella C., Freeman R., Micallef S., Mucenski M.L., Bertoncello I., Ramsay R.G. Defective stem cell factor expression in c-myb null fetal liver stroma. Blood Cells Mol Dis 2001, 27:470-478.
4. Klempnauer K.H., Gonda T.J., Bishop J.M. Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. Cell 1982, 31:453-463.
5. Ivanov X., Mladenov Z., Nedyalkov S., Bozhkov S. Electron-microscope proof of virus particles in fowl myelocytomatosis. C R Acad Bulg Sci 1965, 18:593-595.
6. Introna M., Golay J. How can oncogenic transcription factors cause cancer: a critical review of the myb story. Leukemia 1999, 13:1301-1306.
7. Hanlon L., Barr N.I., Blyth K., Stewart M., Haviernik P., Wolff L., et al. Long-range effects of retroviral insertion on c-myb: overexpression may be obscured by silencing during tumor growth in vitro. J Virol 2003, 77:1059-1068.
8. Shen-Ong G.L., Potter M., Mushinski J.F., Lavu S., Reddy E.P. Activation of the c-myb locus by viral insertional mutagenesis in plasmacytoid lymphosarcomas. Science 1984, 226:1077-1080.
9. Lund A.H., Turner G., Trubetskoy A., Verhoeven E., Wientjens E., Hulsman D., et al. Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice. Nat Genet 2002, 32:160-165.
10. Clappier E., Cuccuini W., Kalota A., Crinquette A., Cayuela J.M., Dik W.A., et al. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. Blood 2007, 110:1251-1261.
11. Lahortiga I., De K.K., Van V.P., Graux C., Cauwelier B., Lambert F., et al. Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. Nat Genet 2007, 39:593-595.
12. O'Neil J., Tchinda J., Gutierrez A., Moreau L., Maser R.S., Wong K.K., et al. Alu elements mediate MYB gene tandem duplication in human T-ALL. J Exp Med 2007, 204:3059-3066.
13. Tomita A., Watanabe T., Kosugi H., Ohashi H., Uchida T., Kinoshita T., et al. Truncated c-Myb expression in the human leukemia cell line TK-6. Leukemia 1998, 12:1422-1429.
14. Hess J.L., Bittner C.B., Zeisig D.T., Bach C., Fuchs U., Borkhardt A., et al. c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells. Blood 2006, 108:297-304.
15. Lidonnici M.R., Corradini F., Waldron T., Bender T.P., Calabretta B. Requirement of c-Myb for p210BCR/ABL-dependent transformation of hematopoietic progenitors and leukemogenesis. Blood 2008, 111:4771-4779.
16. Zuber J., Rappaport A.R., Luo W., Wang E., Chen C., Vaseva A.V., et al. An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. Genes Dev 2011, 25:1628-1640.
17. Waldron T., De D.M., Soliera A.R., Audia A., Iacobucci I., Lonetti A., et al. c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells. Leukemia 2012, 26:644-653.
18. Westin E.H., Gallo R.C., Arya S.K., Eva A., Souza L.M., Baluda M.A., et al. Differential expression of the amv gene in human hematopoietic cells. Proc Natl Acad Sci U S A 1982, 79:2194-2198.
19. Sarvaiya P.J., Schwartz J.R., Hernandez C.P., Rodriguez P.C., Vedeckis W.V. Role of c-Myb in the survival of pre B-cell acute lymphoblastic leukemia and leukemogenesis. Am J Hematol 2012, 87:969-976.
20. Anfossi G., Gewirtz A.M., Calabretta B. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proc Natl Acad Sci U S A 1989, 86:3379-3383.
21. Calabretta B., Sims R.B., Valtieri M., Caracciolo D., Szczylik C., Venturelli D., et al. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging. Proc Natl Acad Sci U S A 1991, 88:2351-2355.
22. Pattabiraman D.R., Gonda T.J. Role and potential for therapeutic targeting of MYB in Leukemia. Leukemia 2012, [Epub ahead of print].
23. Weston K. Myb proteins in life, death and differentiation. Curr Opin Genet Dev 1998, 8:76-81.
24. Ramsay R.G., Gonda T.J. MYB function in normal and cancer cells. Nat Rev Cancer 2008, 8:523-534.
25. Salomoni P., Perrotti D., Martinez R., Franceschi C., Calabretta B. Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity. Proc Natl Acad Sci U S A 1997, 94:3296-3301.
26. Taylor D., Badiani P., Weston K. A dominant interfering Myb mutant causes apoptosis in T cells. Genes Dev 1996, 10:2732-2744.
27. Frampton J., Ramqvist T., Graf T. v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells. Genes Dev 1996, 10:2720-2731.
28. Drabsch Y., Robert R.G., Gonda T.J. MYB suppresses differentiation and apoptosis of human breast cancer cells. Breast Cancer Res 2010, 12:R55.
29. Zorbas M., Sicurella C., Bertoncello I., Venter D., Ellis S., Mucenski M.L., et al. c-Myb is critical for murine colon development. Oncogene 1999, 18:5821-5830.
30. Drabsch Y., Hugo H., Zhang R., Dowhan D.H., Miao Y.R., Gewirtz A.M., et al. Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells. Proc Natl Acad Sci U S A 2007, 104:13762-13767.
31. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
32. Barry S.C., Harder B., Brzezinski M., Flint L.Y., Seppen J., Osborne W.R. Lentivirus vectors encoding both central polypurine tract and posttranscriptional regulatory element provide enhanced transduction and transgene expression. Hum Gene Ther 2001, 12:1103-1108.
33. Brown C.Y., Sadlon T., Gargett T., Melville E., Zhang R., Drabsch Y., et al. Robust, reversible gene knockdown using a single lentiviral short hairpin RNA vector. Hum Gene Ther 2010, 21:1005-1017.
34. Zhao L., Glazov E.A., Pattabiraman D.R., Al-Owaidi F., Zhang P., Brown M.A., et al. Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb. Nucleic Acids Res 2011, 39:4664-4679.
35. Kanei-Ishii C., Nomura T., Tanikawa J., Ichikawa-Iwata E., Ishii S. Differential sensitivity of v-Myb and c-Myb to Wnt-1-induced protein degradation. J Biol Chem 2004, 279:44582-44589.
36. Ramsay R.G., Ciznadija D., Mantamadiotis T., Anderson R., Pearson R. Expression of stress response protein glucose regulated protein-78 mediated by c-Myb. Int J Biochem Cell Biol 2005, 37:1254-1268.
37. Mao J., Luo H., Han B., Bertrand R., Wu J. Drak2 is upstream of p70S6 kinase: its implication in cytokine-induced islet apoptosis, diabetes, and islet transplantation. J Immunol 2009, 182:4762-4770.
38. Sanjo H., Kawai T., Akira S. DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis. J Biol Chem 1998, 273:29066-29071.
39. Matsumoto M., Miyake Y., Nagita M., Inoue H., Shitakubo D., Takemoto K., et al. A serine/threonine kinase which causes apoptosis-like cell death interacts with a calcineurin B-like protein capable of binding Na(+)/H(+) exchanger. J Biochem 2001, 130:217-225.
40. Doherty G.A., Byrne S.M., Austin S.C., Scully G.M., Sadlier D.M., Neilan T.G., et al. Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer. Br J Cancer 2009, 101:483-491.
41. Kogel D., Prehn J.H., Scheidtmann K.H. The DAP kinase family of pro-apoptotic proteins: novel players in the apoptotic game. Bioessays 2001, 23:352-358.
42. Ramos S.J., Hernandez J.B., Gatzka M., Walsh C.M. Enahnced T cell apoptosis within Drak2-deficient mice promotes resistance to autoimmunity. J Immunol 2008, 181:7606-7616.
43. Kissil J.L., Feinstein E., Cohen O., Jones P.A., Tsai Y.C., Knowles M.A., et al. DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene. Oncogene 1997, 15:403-407.
44. Kuwahara H., Nakamura N., Kanazawa H. Nuclear localization of the serine/threonine kinase DRAK2 is involved in UV-induced apoptosis. Biol Pharm Bull 2006, 29:225-233.
45. Mao J., Luo H., Wu J. Drak2 overexpression results in increased beta-cell apoptosis after free fatty acid stimulation. J Cell Biochem 2008, 105:1073-1080.
46. Johnson C.R., Jarvis W.D. Caspase-9 regulation: an update. Apoptosis 2004, 9:423-427.
47. Lei W., Rushton J.J., Davis L.M., Liu F., Ness S.A. Positive and negative determinants of target gene specificity in myb transcription factors. J Biol Chem 2004, 279:29519-29527.
48. Niitsu N., Yamamoto-Yamaguchi Y., Kasukabe T., Okabe-Kado J., Umeda M., Honma Y. Antileukemic efficacy of 2-deoxycoformycin in monocytic leukemia cells. Blood 2000, 96:1512-1516.
49. Ness S.A. Myb protein specificity: evidence of a context-specific transcription factor code. Blood Cells Mol Dis 2003, 31:192-200.
50. Lee S., Chen J., Zhou G., Shi R.Z., Bouffard G.G., Kocherginsky M., et al. Gene expression profiles in acute myeloid leukemia with common translocations using SAGE. Proc Natl Acad Sci U S A 2006, 103:1030-1035.
51. Monroe S.C., Jo S.Y., Sanders D.S., Basrur V., Elenitoba-Johnson K.S., Slany R.K., et al. MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia. Exp Hematol 2011, 39:77-86. e1-5.